Mechema Chemicals Int (4721) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Mechema Chemicals Int stock TWD 38.49, price TWD 65.70, that is 41.4% below the price, quality 71 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 44.25 TWD – 163.48 TWD · fair‑value band 25.92 TWD – 56.77 TWD · the 65.70 TWD price screens above the 38.49 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Mechema Chemicals Int in your weekly email
Every Wednesday you see whether Mechema Chemicals Int is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mechema Chemicals International Corp. manufactures, imports, exports, and trades cobalt acetate, manganese acetate, cobalt compounds, and manganese compounds, as well as engages in the trading, import, and export of cobalt metal and manganese metal in Taiwan, China, South Korea, Thailand, Malaysia, Indonesia, Japan, and internationally.
Show moreShow less
It offers battery cathode and catalyst materials. The company provides sulfate, acetate, and bromide solution molecular cobalt related products; sulfate, chloride, carbonate, and acetate nickel; and black and green nickel oxide products.
In addition, it offers CTA waste catalyst recovery and PTA mother liquor systems. Mechema Chemicals International Corp. was founded in 1981 and is based in Taoyuan City, Taiwan.
Stock analysis
Mechema Chemicals Int (4721) currently trades at 65.70 TWD, while our model-based Fair Value estimate is 38.49 TWD, 41% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 50.90 TWD per share, and 1 of the 26 models we run sit above the 65.70 TWD price.
Bear case: the Asset-Based group reads lowest at 10.40 TWD, and 25 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: 25.92 TWD (bear) to 56.77 TWD (bull), the price of 65.70 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 71/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Mechema Chemicals Int reported revenue of 2.5B TWD in FY2025 versus 4.1B TWD in FY2021, a compound −11.5%/yr. Reported net income was 226M TWD in FY2025, compounding −11.1%/yr from FY2021.
Key figures
Market cap 4.9B TWD (≈ $150M) Micro · P/E ratio 13.2 · P/S ratio 1.87 · EPS (TTM) 4.96 TWD · Dividend yield 3.5% · Net margin 14.1% · Return on equity 28.4% · Return on assets (EBIT) 14.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 72 out of 100 (low confidence).
What moves the price
The share trades about 35% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −41%, 4721 screens cheaper than that median.
Fair Value models
Bear25.92 TWDFair Value 38.49 TWDBull56.77 TWD
Price 65.70 TWD · Downside -41.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (2.28 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+19.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−21.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.5%
Start year 2020 (pandemic). Over 10 years: +2.3% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+4.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.6%
Dividend (yield on the price)3.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.0.6% vs 6.9%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 12%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+35.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +33.1% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score71 · Top 25%
Fair Value upside−41.4% · Below median
Profitability
Return on equity (12 months)28.4% · Top 25%
Return on assets10.2% · Top 25%
Net margin (12 months)14.1% · Top 25%
Operating margin (12 months)20.7% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)−17.5% · Bottom 25%
Dividend yield (12 months)3.5% · Top 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mechema Chemicals Int Fair Value". https://www.fairvalue-calculator.com/stock/4721
Frequently asked questions
Is Mechema Chemicals Int (4721) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 38.49 TWD versus a price of 65.70 TWD, about 41% lower (overvalued).
What is the fair value of 4721?
Our model-based fair value for Mechema Chemicals Int is 38.49 TWD (as of Nov 8, 2026), built from audited fundamentals. The current price: 65.70 TWD.
What is the quality score of 4721?
Mechema Chemicals Int has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mechema Chemicals Int (4721)?
Our model-based price target is the fair value of 38.49 TWD (as of Nov 8, 2026) from 26 valuation models. Cautious scenario 25.92 TWD, optimistic scenario 56.77 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Mechema Chemicals Int stock forecast for 2026?
Our models put fair value at 38.49 TWD, about 41% lower versus a price of 65.70 TWD (overvalued). Cautious scenario 25.92 TWD, optimistic scenario 56.77 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Mechema Chemicals Int (4721)?
Mechema Chemicals Int reported trailing-twelve-month revenue of about 2.6B TWD (latest available figure, as of Nov 8, 2026).
Does Mechema Chemicals Int pay a dividend?
Mechema Chemicals Int currently shows a dividend yield of 3.50% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Mechema Chemicals Int (4721) and when is the ex-dividend date?
Mechema Chemicals Int pays a dividend of 2.30 TWD per share a year, a dividend yield of 3.5%. The last ex-dividend date was Jul 15, 2026. A dividend has been paid every year since at least 2008. The payout ratio is 46.4% of earnings. Free cash flow covers the dividend 0.65 times. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What growth is priced into Mechema Chemicals Int (4721)?
For today's price to be fair in a discounted-cash-flow model, Mechema Chemicals Int would have to grow free cash flow by +35.2 % per year for five years (discount rate 13.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.5 % per year. Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 4721 use?
Our models discount Mechema Chemicals Int at 13.0 %: a base by market capitalisation (micro), damped by beta 0.93, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mechema Chemicals Int that is +35.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.0 %) and the same formula as our fair value.
How much growth has Mechema Chemicals Int (4721) delivered so far?
Over the past 5 years revenue at Mechema Chemicals Int grew +2.5 % a year. The price currently implies free-cash-flow growth of +35.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Mechema Chemicals Int (4721) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Mechema Chemicals Int (+35.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Mechema Chemicals Int (4721)?
The free-cash-flow yield on the price is 2.28 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Mechema Chemicals Int produces per unit of market value. When it exceeds the discount rate of our models (13.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Mechema Chemicals Int (4721)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mechema Chemicals Int it is 38.49 TWD per share (as of Nov 8, 2026), against a price of 65.70 TWD. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Mechema Chemicals Int stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 4721 trades above its calculated fair value: price 65.70 TWD, fair value 38.49 TWD, a gap of about −41% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4721?
No. The price is what the market pays today (65.70 TWD); the fair value is what the company's own numbers justify (38.49 TWD). For Mechema Chemicals Int the two are 27.21 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Mechema Chemicals Int worth?
The market values Mechema Chemicals Int at about 4.9B TWD (market capitalisation, as of Nov 8, 2026). Per share that is 65.70 TWD; our models calculate a fair value of 38.49 TWD per share.
What do the bullish and bearish scenarios say about 4721?
Our models span a range for Mechema Chemicals Int: cautious scenario 25.92 TWD, base 38.49 TWD, optimistic 56.77 TWD per share (as of Nov 8, 2026, price 65.70 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4721?
Mechema Chemicals Int trades at a price-to-earnings ratio of 13.2 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 38.49 TWD is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings: 23.7. Other multiples: P/B 3.6, P/S 1.9, EV/EBITDA 8.4.
How solid is the balance sheet of Mechema Chemicals Int (4721)?
Balance-sheet figures for Mechema Chemicals Int (as of Nov 8, 2026): return on equity 28.4%. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is 4721 from its 52-week high?
Mechema Chemicals Int trades at 65.70 TWD, about 35% below its 52-week high of 101.00 TWD and 7% above the low of 61.20 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 38.49 TWD is for.
Which stocks are comparable to Mechema Chemicals Int?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mechema Chemicals Int stock attractive at the current price?
The data as of Nov 8, 2026: price 65.70 TWD, calculated fair value 38.49 TWD (−41%), Quality Score 71/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4721 calculated?
We run Mechema Chemicals Int through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 38.49 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Mechema Chemicals Int itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mechema Chemicals Int (4721)?
The closing price on Nov 6, 2026 was 65.70 TWD. Our model-based fair value is 38.49 TWD, about 41% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mechema Chemicals Int right now?
The price sits above even our optimistic bull case (56.77 TWD). The favourable scenario is already priced in. Solid but not exceptional quality (71/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (25.92 TWD to 56.77 TWD) leaves room in how you read the outcome.
Where does the earnings growth of Mechema Chemicals Int (4721) come from?
Earnings per share at Mechema Chemicals Int grew +18.8 % a year from 2012 to 2023. Broken into its drivers: revenue per share +8.7 %, EBIT margin +16.2 %, tax rate −0.5 %, residual (interest, one-offs) −5.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Mechema Chemicals Int
How large is the market capitalisation of Mechema Chemicals Int (4721)?
The market capitalisation of Mechema Chemicals Int is 4.9B TWD (≈ $150M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mechema Chemicals Int (4721)?
The price-to-sales ratio of Mechema Chemicals Int is 1.87 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mechema Chemicals Int (4721)?
Earnings per share at Mechema Chemicals Int are 4.96 TWD (price ÷ EPS = P/E 13.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Mechema Chemicals Int (4721)?
The dividend yield of Mechema Chemicals Int is 3.5% (payout 46.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Mechema Chemicals Int (4721)?
The net margin of Mechema Chemicals Int is 14.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mechema Chemicals Int (4721)?
The return on equity (ROE) of Mechema Chemicals Int is 28.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mechema Chemicals Int (4721)?
On an EBIT basis the return on assets of Mechema Chemicals Int is 14.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mechema Chemicals Int (4721)?
The operating margin of Mechema Chemicals Int is 20.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mechema Chemicals Int (4721)?
Revenue at Mechema Chemicals Int is growing −17.5% versus a year earlier (3y avg −21.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Mechema Chemicals Int (4721)?
Earnings per share at Mechema Chemicals Int are growing +129% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Mechema Chemicals Int (4721) carry?
The net debt of Mechema Chemicals Int is 203M TWD (fiscal year 2025, ≈ 1.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Mechema Chemicals Int in the live analysis
One click puts Mechema Chemicals Int on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026